Volume 9, Issue 1 (3-2021)                   Jorjani Biomed J 2021, 9(1): 5-8 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Shekarriz Z, Shorofi S A, Nabati M, jokar A, Yousefi S S. Traditional Persian Medicine for the Management of Hypertension. Jorjani Biomed J. 2021; 9 (1) :5-8
URL: http://goums.ac.ir/jorjanijournal/article-1-760-en.html
1- Mazandaran University of Medical Sciences, Sari, Iran/ Student Research Committee, Traditional and Complementary Medicine Research Center, Addiction Institute, Mazandaran University of Medical Sciences, Sari, Iran
2- Department of Medical Surgical Nursing, School of Nursing and Midwifery, Mazandaran University of Medical Sciences, Sari, Iran/ Adjunct Research Fellow, Flinders, University, Adelaide, Australia
3- Department of Cardiology, School of Medicine, Cardiovascular Research Center, Sari Fatemeh Zahra Hospital, Mazandaran University of Medical Sciences, Sari, Iran
4- Mazandaran University of Medical Sciences, Sari, Iran
5- Mazandaran University of Medical Sciences, Sari, Iran , Dr_ssyosefi@yahoo.com
Abstract:   (1076 Views)
Hypertension is a major risk factor for the cardiovascular diseases. One of the factors contributing to blood pressure is peripheral vascular resistance. Vascular stiffness plays a key role in developing the hypertension, leading to increased systolic blood pressure and pulse pressure. from Avicenna s perspective, the blood pressure caused by 1- Increased blood volume 2- Warm heart dystemperament which leads to the hyperactivity of heart pump and increased cardiac output 3- A vascular disorder called "Tasallob Sharaeen”  "atherosclerosis".  So, one of Avicennachr s recommendations for the prevention and treatment of hypertension is the consumption of Moisturizing foods and beverages and fruits. One of these moisturizing products which are very useful is “whey Protein”. It seems that by studying ancient Iranian medicine s general books, new and effective solutions can be provided in the prevention and treatment of diseases.
Full-Text [PDF 313 kb]   (366 Downloads) |   |   Full-Text (HTML)  (118 Views)  
Type of Article: Letter to Editor | Subject: General medicine
Received: 2020/12/20 | Accepted: 2021/01/28 | Published: 2021/02/9

1. Organization WHO. A global brief on hypertension: silent killer, global public health crisis: World Health Day 2013. World Health Organization; 2013. [Google Scholar]
2. Fields LE, Burt VL, Cutler JA, Hughes J, Roccella EJ, Sorlie P. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension. 2004;44(4):398-404. [view at publisher] [DOI] [Google Scholar]
3. Bonow RO MD, Zipes DP, Libby P. Braunwald, s Heart Disease: A Textbook of Cadiovascular Medicine, 2-Volume Set: Elsevier Health Sciences; 2015. [Google Scholar]
4. Shoja MM, Tubbs RS, Loukas M, Khalili M, Alakbarli F, Cohen-Gadol AA. Vasovagal syncope in the Canon of Avicenna: the first mention of carotid artery hypersensitivity. International journal of cardiology. 2009;134(3):297-301. [view at publisher] [DOI] [Google Scholar]
5. Choopani R, Mosaddegh M, Gir AA-dG, Emtiazy M. Avicenna (Ibn Sina) aspect of atherosclerosis. International journal of cardiology. 2012;156(3):330. [DOI] [Google Scholar]
6. Turgut O, Manduz S, Tandogan I. Avicenna: messages from a great pioneer of ancient medicine for modern cardiology. International journal of cardiology. 2010;145(2):222. [view at publisher] [DOI] [Google Scholar]
7. Gharooni M, Ghods R, Gholamreza A, Nazem E, Nasrabadi AN. Probable etiology of hypertension according to the Iranian traditional medicine. Iranian journal of public health. 2014;43(6):851. [view at publisher] [Google Scholar]
8. Trion A, van der Laarse A. Vascular smooth muscle cells and calcification in atherosclerosis. American heart journal. 2004;147(5):808-14. [view at publisher] [DOI] [Google Scholar]
9. Arzani Hakim MA. In: teb-e-Akbari. Ehya Teb e Tabiee O eTJP. [Google Scholar]
10. Hosseini A, Azadbakht M, Yousofpoor M. 'Maoljobon'A Drug in Iranian Traditional Medicine. Journal of Mazandaran University of Medical Sciences. 2017;26(146):269-78. [Google Scholar]
11. De Aguilar-Nascimento JE, Silveira BRP, Dock-Nascimento DB. Early enteral nutrition with whey protein or casein in elderly patients with acute ischemic stroke: a double-blind randomized trial. Nutrition. 2011;27(4):440-4. [view at publisher] [DOI] [Google Scholar]
12. Pal S, Ellis V. The chronic effects of whey proteins on blood pressure, vascular function, and inflammatory markers in overweight individuals. Obesity. 2010;18(7):1354-9. [view at publisher] [DOI] [Google Scholar]
13. Stepaniak L, Sorhaug T, Jedrychowski L, Wroblewska B. Immunoreactivity and inhibition of angiotensin I converting enzyme and lactococcal oligopeptidase by peptides from cheese. Italian Journal of Food Science (Italy). 2001. [Google Scholar]
14. FitzGerald RJ, Meisel H. Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme. British Journal of Nutrition. 2000;84(S1):33-7. [view at publisher] [DOI] [Google Scholar]
15. Sipola M, Finckenberg P, Vapaatalo H, Pihlanto-Leppälä A, Korhonen H, Korpela R, et al. α-Lactorphin and β-lactorphin improve arterial function in spontaneously hypertensive rats. Life Sciences. 2002;71(11):1245-53. [view at publisher] [DOI] [Google Scholar]

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2021 CC BY-NC 4.0 | Jorjani Biomedicine Journal

Designed & Developed by : Yektaweb